Semaglutide, liraglutide, dulaglutide, exenatide, albiglutide, and lixisenatide are all medications in the GLP-1 receptor agonist class, which are primarily used to improve blood sugar control in people with type 2 diabetes and, in some cases, to support chronic weight management
A booking fee is required at the time you make your consultation or treatment appointment
The oral vs injection effectiveness comparison covers the evidence for tirzepatide specifically
What emerges is a coherent biological framework: estrogen maintains the mitochondrial infrastructure and synaptic stability that neurons depend on for sustained function, while GLP-1 receptor activation reduces the inflammatory burden that progressively degrades that infrastructure
Robert Kushner: Well, the BMI classifications, the cut points you mentioned, have actually now been removed by the FDA for semaglutide and the other drug called tirzepatide, the two major drugs on the market
Lancet 397(10271):293304